Gene rearrangements in the RET gene are detected in approximately 1% to 2% of patients with NSCLC and affect signaling pathways such as PI3K/AKT, JAK-STAT, and RAS/MAPK. Here, PIK3CA is linked to non-small cell lung carcinoma.